4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and risk of restenosis after coronary artery stenting

MLA

Bottiger, Carinna, et al. “4G/5G Polymorphism of the Plasminogen Activator Inhibitor-1 Gene and Risk of Restenosis after Coronary Artery Stenting.” American Heart Journal, vol. 146, no. 5, Nov. 2003, p. 855. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.125055456&authtype=sso&custid=ns315887.

APA

Bottiger, C., Koch, W., Lahn, C., Mehilli, J., Becherath, N. V., Schomig, A., & Kastrati, A. (2003). 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and risk of restenosis after coronary artery stenting. American Heart Journal, 146(5), 855.

Chicago

Bottiger, Carinna, Werner Koch, Christina Lahn, Julinda Mehilli, Nicolas Van Becherath, Albert Schomig, and Adnan Kastrati. 2003. “4G/5G Polymorphism of the Plasminogen Activator Inhibitor-1 Gene and Risk of Restenosis after Coronary Artery Stenting.” American Heart Journal 146 (5): 855. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.125055456&authtype=sso&custid=ns315887.